This is an extension study for subjects who participated in Protocol 20090061. All subjects in this study will receive a 210mg injection of AMG827 for treatment for their Rheumatoid Arthritis for up to 5 years.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01059448?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
